Terms: = Lung cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
53 results:
1. Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.
Shibaki R; Fujimoto D; Nozawa T; Sano A; Kitamura Y; Fukuoka J; Sato Y; Kijima T; Matsumoto H; Yokoyama T; Miura S; Hata A; Tamiya M; Taniguchi Y; Sugisaka J; Furuya N; Tanaka H; Yamamoto N; Koh Y; Akamatsu H
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38360040
[TBL] [Abstract] [Full Text] [Related]
2. Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study.
Kim TH; Choi JH; Ahn MS; Lee HW; Kang SY; Choi YW; Koh YW; Sheen SS
BMC Cancer; 2024 Jan; 24(1):70. PubMed ID: 38216948
[TBL] [Abstract] [Full Text] [Related]
3. A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study.
Wu Z; Tan F; Xie Y; Tang W; Wang F; Xu Y; Cao W; Qin C; Dong X; Zheng Y; Luo Z; Wang C; Zhao L; Xia C; Li J; Li R; Feng F; Li J; Ren J; Shi J; Cui H; Shen S; Wu N; Chen W; Li N; He J
Cancer Med; 2023 Jul; 12(13):14781-14793. PubMed ID: 37199391
[TBL] [Abstract] [Full Text] [Related]
4. Trends in Survival Rates of Non-Small Cell lung cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
5. Radiomics feature analysis and model research for predicting histopathological subtypes of non-small cell lung cancer on CT images: A multi-dataset study.
Song F; Song X; Feng Y; Fan G; Sun Y; Zhang P; Li J; Liu F; Zhang G
Med Phys; 2023 Jul; 50(7):4351-4365. PubMed ID: 36682051
[TBL] [Abstract] [Full Text] [Related]
6. Combined Radiomics-Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell lung cancer.
Chen W; Wang L; Hou Y; Li L; Chang L; Li Y; Xie K; Qiu L; Mao D; Li W; Xia Y
Technol Cancer Res Treat; 2022; 21():15330338221142400. PubMed ID: 36476110
[No Abstract] [Full Text] [Related]
7. The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis.
Ma JC; Zhang JX; Wang F; Yu J; Chen D
Front Immunol; 2022; 13():1039157. PubMed ID: 36451822
[TBL] [Abstract] [Full Text] [Related]
8. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell lung cancer: A Retrospective Multicohort Study.
Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
Front Immunol; 2022; 13():859323. PubMed ID: 35572597
[TBL] [Abstract] [Full Text] [Related]
9. lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival.
Miller HA; Rai SN; Yin X; Zhang X; Chesney JA; van Berkel VH; Frieboes HB
Metabolomics; 2022 May; 18(5):31. PubMed ID: 35567637
[TBL] [Abstract] [Full Text] [Related]
10. Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I lung cancer Treated With Stereotactic Body Radiotherapy.
Tahir I; Marquardt JP; Mercaldo ND; Bourgouin PP; Wrobel MM; Mrah S; Sharp GC; Khandekar MJ; Willers H; Keane FK; Fintelmann FJ
AJR Am J Roentgenol; 2022 Oct; 219(4):579-589. PubMed ID: 35416054
[No Abstract] [Full Text] [Related]
11. Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
Hong SY; Lu YC; Hsiao SH; Kao YR; Lee MH; Lin YP; Wang CY; Wu CW
Oncogene; 2022 Mar; 41(13):1907-1917. PubMed ID: 35149839
[TBL] [Abstract] [Full Text] [Related]
12. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
[TBL] [Abstract] [Full Text] [Related]
13. Stereotactic Body Radiation Therapy for Apical lung Tumors: Dosimetric Analysis of the Brachial Plexus and Preliminary Clinical Outcomes.
Morse RT; Doke K; Ganju RG; Sood S; Mavroidis P; Chen AM
Pract Radiat Oncol; 2022; 12(3):e183-e192. PubMed ID: 34929402
[TBL] [Abstract] [Full Text] [Related]
14. Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
Metheny L; Callander NS; Hall AC; Zhang MJ; Bo-Subait K; Wang HL; Agrawal V; Al-Homsi AS; Assal A; Bacher U; Beitinjaneh A; Bejanyan N; Bhatt VR; Bredeson C; Byrne M; Cairo M; Cerny J; DeFilipp Z; Perez MAD; Freytes CO; Ganguly S; Grunwald MR; Hashmi S; Hildebrandt GC; Inamoto Y; Kanakry CG; Kharfan-Dabaja MA; Lazarus HM; Lee JW; Nathan S; Nishihori T; Olsson RF; Ringdén O; Rizzieri D; Savani BN; Savoie ML; Seo S; van der Poel M; Verdonck LF; Wagner JL; Yared JA; Hourigan CS; Kebriaei P; Litzow M; Sandmaier BM; Saber W; Weisdorf D; de Lima M
Transplant Cell Ther; 2021 Nov; 27(11):923.e1-923.e12. PubMed ID: 34428556
[TBL] [Abstract] [Full Text] [Related]
15. Long-term outcome following microwave ablation of early-stage non-small cell lung cancer.
Zhao H; Steinke K
J Med Imaging Radiat Oncol; 2020 Dec; 64(6):787-793. PubMed ID: 32720747
[TBL] [Abstract] [Full Text] [Related]
16. β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
Deng M; Liu B; Song H; Yu R; Zou D; Chen Y; Ma Y; Lv F; Xu L; Zhang Z; Lv Q; Yang X; Che X; Qu X; Liu Y; Zhang Y; Hu X
Phytomedicine; 2020 Apr; 69():153184. PubMed ID: 32199253
[TBL] [Abstract] [Full Text] [Related]
17. Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood cancer Survivor Study.
Dietz AC; Seidel K; Leisenring WM; Mulrooney DA; Tersak JM; Glick RD; Burnweit CA; Green DM; Diller LR; Smith SA; Howell RM; Stovall M; Armstrong GT; Oeffinger KC; Robison LL; Termuhlen AM
Lancet Oncol; 2019 Oct; 20(10):1420-1431. PubMed ID: 31471158
[TBL] [Abstract] [Full Text] [Related]
18. [Activation of coagulation in patients with lung cancer].
Hammouda A; Souilah S; Ferhat-Hamida MY; Amir ZC; Aouichat-Bouguerra S; Hariti G
Ann Biol Clin (Paris); 2019 Jun; 77(3):272-280. PubMed ID: 31219420
[TBL] [Abstract] [Full Text] [Related]
19. Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer.
Kim CG; Kim KH; Pyo KH; Xin CF; Hong MH; Ahn BC; Kim Y; Choi SJ; Yoon HI; Lee JG; Lee CY; Park SY; Park SH; Cho BC; Shim HS; Shin EC; Kim HR
Ann Oncol; 2019 Jul; 30(7):1104-1113. PubMed ID: 30977778
[TBL] [Abstract] [Full Text] [Related]
20. Serum α-1 Acid Glycoprotein is a Biomarker for the Prediction of Targeted Therapy Resistance in Advanced EGFR-positive lung Adenocarcinoma.
Xu YF; Xu Y; Li X; Yang XM
Comb Chem High Throughput Screen; 2018; 21(10):755-759. PubMed ID: 30663564
[TBL] [Abstract] [Full Text] [Related]
[Next]
